Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.22.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of summary of stock option activity
The following is a summary of option activities under the Company’s 2014 Plan for the three months ended March 31, 2022:
Number of
Shares		 Weighted
Average
Exercise Price		 Weighted
Average
Remaining
Contractual
Term (Years)		 Aggregate Intrinsic Value
Outstanding, December 31, 2021 35,405,000  $ 0.07  9.08 $ 134,750 
Granted —  — 
Exercised —  — 
Cancelled (215,000) 0.07 
Forfeited (825,000) 0.10 
Outstanding, March 31, 2022 34,365,000  $ 0.07  8.82 $ — 
Exercisable, March 31, 2022 11,331,250  $ 0.08  8.82 $ — 
Exercisable, Vested and expected to vest, March 31, 2022 34,365,000  $ 0.07  8.82 $ — 
Schedule of RSA activity
The following is a summary of restricted stock activity outside of the Company’s 2014 Plan during the three months ended March 31, 2022:
Number of
Shares		 Weighted
Average
Grant
Date Fair
Value
Unvested, December 31, 2021 150,000  $ 0.13 
Released (150,000) 0.13 
Unvested, March 31, 2022 —  $ — 
Schedule of stock-based compensation expense The Company recognized stock-based compensation expense, including compensation expense for RSUs discussed above, in its Condensed Consolidated Statements of Comprehensive Loss as follows:
Three Months Ended March 31,
2022 2021
Research and development $ 18,585  $ 74,429 
General and administrative 118,773  72,151 
$ 137,358  $ 146,580